Clinical Trials – Page 22

GSK’s Therapeutic Herpes Vaccine Fails to Meet Efficacy Objective in Phase I/II Trial

10 months ago talkbio0Tagged Clinical Trials, Failure (biologic function), Herpes Simplex Infections, Simplexvirus, SmithKline Beecham, Vaccines

GSK, therapeutic herpes vaccine, herpes simplex virus, HSV, vaccine failure, clinical trial

Novo Nordisk Reports Significant Weight Loss with New Dual-Acting Oral Drug in Early Clinical Trial

10 months ago talkbio0Tagged Agonist, Clinical Trials, dual-acting oral drug, Glucagon-Like Peptide-1 Receptor, Nordisk, Obesity

Novo Nordisk, weight loss, dual-acting oral drug, early clinical trial, obesity treatment, GLP-1 receptor agonist

Viridian Therapeutics’ Veligrotug Achieves Positive Topline Results in Phase 3 THRIVE Clinical Trial for Thyroid Eye Disease

10 months ago talkbio0Tagged Antibodies, biopharmaceutical development, Clinical Trials, Phase 3, Success, Thrive, Thyroid associated opthalmopathies, Veligrotug, VRDN-001

Veligrotug (VRDN-001), Thyroid Eye Disease (TED), Phase 3 THRIVE Clinical Trial, Anti-IGF-1R Antibody, Clinical Trial Success, Biopharmaceutical Development

Centessa’s ORX750 Demonstrates Promising ‘Best-in-Class’ Profile in Early Narcolepsy Trial

10 months ago talkbio0Tagged Agonist, Centessa Pharmaceuticals, Clinical Trials, Narcolepsy, ORX750, Phase 1 (qualifier value), sleep-wake disorders

Centessa Pharmaceuticals, ORX750, narcolepsy, orexin receptor 2 agonist, sleep-wake disorders, clinical trial, Phase 1 data

Superluminal Medicines Secures $120M Series A Funding to Advance Membrane Receptor Drugs into Clinical Trials

10 months ago talkbio0Tagged AI-focused, Clinical Trials, Eli, Eli Lilly, Funding, Investments, Membrane receptor, Series, Superluminal Medicines

Superluminal Medicines, Series A funding, membrane receptor drugs, clinical trials, AI-focused biotech, Eli Lilly investment